Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thoracic Radiotherapy Combined With EGFR-TKI for Wild-type Non-small Cell Lung Cancer

NCT02738983 is registered in ClinicalTrials.gov with Hangzhou Cancer Hospital as lead sponsor.

NCT NCT02738983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02738983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thoracic Radiotherapy Combined With EGFR-TKI for Wild-type Non-small Cell Lung Cancer
Lead sponsor
Hangzhou Cancer Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2012
Completion date
December 31, 2017
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki), non-small cell lung cancer